Biodexa Pharmaceuticals Plc ADR [NASDAQ: BDRX] gained 14.29% on the last trading session, reaching $4.40 price per share at the time.
If compared to the average trading volume of 161.31K shares, BDRX reached a trading volume of 5808764 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about Biodexa Pharmaceuticals Plc ADR [BDRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BDRX shares is $200.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BDRX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Biodexa Pharmaceuticals Plc ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 08, 2024.
The Average True Range (ATR) for Biodexa Pharmaceuticals Plc ADR is set at 0.86, with the Price to Sales ratio for BDRX stock in the period of the last 12 months amounting to 25.52. The Price to Book ratio for the last quarter was 0.35, with the Price to Cash per share for the same quarter was set at 11.02.
Trading performance analysis for BDRX stock
Biodexa Pharmaceuticals Plc ADR [BDRX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.47. With this latest performance, BDRX shares dropped by -37.77% in over the last four-week period, additionally sinking by -84.00% over the last 6 months – not to mention a drop of -93.69% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BDRX stock in for the last two-week period is set at 39.46, with the RSI for the last a single of trading hit 41.53, and the three-weeks RSI is set at 38.60 for Biodexa Pharmaceuticals Plc ADR [BDRX]. The present Moving Average for the last 50 days of trading for this stock 6.24, while it was recorded at 3.82 for the last single week of trading, and 19.95 for the last 200 days.
Biodexa Pharmaceuticals Plc ADR [BDRX]: A deeper dive into fundamental analysis
Biodexa Pharmaceuticals Plc ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.16 and a Current Ratio set at 2.16.
